Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kestra Medical Technologies, Ltd. (KMTS:NASDAQ), powered by AI.
Kestra Medical Technologies, Ltd. is currently trading at $19.23. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kestra Medical Technologies, Ltd. on Alpha Lenz.
Kestra Medical Technologies, Ltd.'s P/E ratio is -4.2.
“Kestra Medical Technologies, Ltd. trades at a P/E of -4.2 (undervalued) with strong ROE of 5732.3%.”
Ask for details →Kestra Medical Technologies Inc. is a company specializing in the development and production of innovative medical devices. The core function of Kestra is to design wearable medical technologies aimed at improving patient outcomes in critical health areas. Primarily, the company engages in creating devices that focus on cardiac care, providing solutions that monitor, diagnose, and assist in the management of heart conditions. Kestra Medical Technologies addresses significant needs within the healthcare sector, particularly impacting the cardiology field by offering devices that enhance both the quality and efficiency of patient care. As a player in the medical technology industry, Kestra is positioned to influence patient health management trends and contribute to the advancement of medical device technologies. Its products serve as critical tools for healthcare providers aiming to offer cutting-edge care solutions.
“Kestra Medical Technologies, Ltd. trades at a P/E of -4.2 (undervalued) with strong ROE of 5732.3%.”
Ask for details →Kestra Medical Technologies, Ltd. (ticker: KMTS) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 330 employees. Market cap is $473M.
The current price is $19.23 with a P/E ratio of -4.15x and P/B of 2.3x.
ROE is 5732.26% and operating margin is -177.84%. Annual revenue is $60M.